Leake, J. Et Al. 2017. FDG PET/CT tumor heterogeneity: A predictive imaging biomarker for immunotherapy treatment response of metastatic melanoma. Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI) , (Colorado, United States Of America).

Leake, J., ŞANLI, Y., Xi, Y., Odu, A., & Subramaniam, R., (2017). FDG PET/CT tumor heterogeneity: A predictive imaging biomarker for immunotherapy treatment response of metastatic melanoma . Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Colorado, United States Of America

Leake, James Et Al. "FDG PET/CT tumor heterogeneity: A predictive imaging biomarker for immunotherapy treatment response of metastatic melanoma," Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Colorado, United States Of America, 2017

Leake, James Et Al. "FDG PET/CT tumor heterogeneity: A predictive imaging biomarker for immunotherapy treatment response of metastatic melanoma." Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI) , Colorado, United States Of America, 2017

Leake, J. Et Al. (2017) . "FDG PET/CT tumor heterogeneity: A predictive imaging biomarker for immunotherapy treatment response of metastatic melanoma." Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI) , Colorado, United States Of America.

@conferencepaper{conferencepaper, author={James Leake Et Al. }, title={FDG PET/CT tumor heterogeneity: A predictive imaging biomarker for immunotherapy treatment response of metastatic melanoma}, congress name={Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI)}, city={Colorado}, country={United States Of America}, year={2017}}